Efficacy and Limitation of F-18-fluorodeoxyglucose Positron Emission Tomography during Fasting to Assess Myocardial Viability in the Acute Phase of Myocardial Infarction

Internal Medicine

Volumn 37, Issue 8, 1998, Pages 653-661

  Nonogi, Hiroshi ^a   Miyazaki, Shunichi ^a   Goto, Yoichi ^a   Ishida, Yoshio ^a   Uehara, Toshiisa ^b   Nishimura, Tsunehiko ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Glucose; Ischemia; Reperfusion; Scintigram

Indexed keywords

FIBRINOLYTIC AGENT; FLUORODEOXYGLUCOSE F 18; THALLIUM CHLORIDE TL 201; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICULOGRAPHY; HUMAN; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSLUMINAL CORONARY ANGIOPLASTY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ACUTE DISEASE; ADULT; AGED; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031686340     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.653     Document Type: Article

References (19)

1. Brunken RC, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion detects. J Am Coll Cardiol 10: 557, 1987.
2. Tamaki N, Yonekura Y, Yamashita K, et al.Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 64: 860, 1989.
3. Schwaiger M, Schelbert HR, Ellison D, et al.Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 6: 336, 1985.
4. Schwaiger M, Brunken R, Grover-McKay M, et al.Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 8: 800, 1986.
5. Chesebro JH, Kuatterud G, Roberts R, et al.Thrombolysis in myocardial infarction (TIMI) trial, phase 1: acomparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76: 142, 1987.
6. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary occlusion in human subjects: a prospective study. Circulation 74: 469, 1986.
7. Brunken RC, Mody FV, Hawkins RA, Nienaber C, Phelps ME, Schelbert HR. Positron emission tomography defects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201TL defects. Circulation 86: 1357, 1992.
8. Heger JJ, Weyman AE, Wann LS, Dillon JC, Feigenbaum H. Cross-sectional echocardiography in acute myocardial infarction: detection and localization of regional left ventricular asynergy. Circulation 60: 531, 1979.
9. Melin JA, Wijns W, Keyeux A, et al.Assessment of thallium-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion. Circulation 77: 927, 1988.
10. Sochor H, Schwaiger M, Schelbert HR, et al.Relationship between TI-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. Am Heart J 114: 1066, 1987.
11. Camici P, Araujo LI, Spinks T, et al.Increased uptake of 18-F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina. Circulation 74: 81, 1986.
12. Schwaiger M, Schelbert HR, Keen R, et al.Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium. J Am Coll Cardiol 6: 311, 1985.
13. Lopaschuk CD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 66: 546, 1990.
14. Liedtke AJ, Renstrom B, Nellis SH. Correlation between [5-3-H] glucose and [U-14-C] deoxyglucose as markers of glycolysis in reperfused myocardium. Circ Res 71: 689, 1992.
15. Wijns W, Melin JA, Leners N, et al.Accumulation of polymorphonuclear leukocytes in reperfused ischemic canine myocardium: relation with tissue viability assessed by fluorine-18-2-deoxy-glucose uptake. J Nucl Med 29: 1826, 1988.
16. Sease D, Garza D, Merhige ME, Gould KL. Does myocardial uptake of F-18-fluorodeoxyglucose by positron emission tomography reliably indicate myocardial viability in acute myocardial infarction? Circulation 80: (suppl II): II-378, 1989 (Abstract).
17. Sebree L, Bianco JA, Subramanian R, et al.Discordance between accumulation of C-14 deoxyglucose and TL-201 in reperfused myocardium. J Mol Cell Cardiol 23: 603, 1991.
18. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function, and metabolism. Circulation 85: 1347, 1992.
19. The GISSI-3 APPI Study Group. Early and six-month outcome in patients with angina pectoris early after acute myocardial infarction (The GISSI-3 APPI [Angina Precoce Post-Infano] study). Am J Cardiol 78: 1191, 1996.